MarketPeel
Insider Trading Intelligence
Pricing
…
BL

Bios Advisors Gp, Llc

LTRN
10% OWNER · LANTERN PHARMA INC. · CIK 0001813844
FILING MIX · LIFETIME46%/54%
BUYS
111
SELLS
128
TOTAL VALUE
$15.36B
COMPANIES
5
ACTIVE SINCE
Jun 2020
HOLDINGS NOW
916,015
AVG SELL PX
$4.36
TRADE KIND
SHOWING 239 / 239
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
33 backtested trades · 8 horizons · 4 pending
Forward-return performance of every backtestable P/S trade by Bios Advisors Gp, Llc, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d33+24.24%-4.17%-0.21%-3.96%-2.80%-1.48
14d33+57.58%+0.06%-0.04%+0.09%-8.40%0.02
30d33+57.58%-0.46%+0.72%-1.18%-4.86%-0.23
60d33+48.48%-14.29%-0.30%-13.99%-24.61%-2.31
90d33+39.39%-24.32%+1.92%-26.24%-35.67%-4.51
180d33+42.42%-29.61%+7.17%-36.79%-34.13%-5.43
1y33+42.42%-59.16%+16.44%-75.61%-58.30%-13.32
2y33(4 pending)+48.28%-67.18%+44.34%-111.52%-100.31%—
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
LTRN · 189,117 shares · as of Jun 13, 2025
0167,185334,369501,554668,73820212022202320242025SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 111 buys / 128 sellsCOVERAGE · 25 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
CGTX
COGNITION THERAPEUTICS INC
PURCHASEGRANT
Stock grant
25,000——81,229Jun 17, 2026Jun 22, 2026 ↗View →
ACTU
ACTUATE THERAPEUTICS, INC.
PURCHASE
71,428$7.00$500.0K196,428Jun 27, 2025Jun 30, 2025 ↗View →
ACTU
ACTUATE THERAPEUTICS, INC.
PURCHASE
71,428——71,428Jun 27, 2025Jun 30, 2025 ↗View →
CGTX
COGNITION THERAPEUTICS INC
PURCHASEGRANT
Stock grant
34,000——48,500Jun 18, 2025Jun 20, 2025 ↗View →
LTRN
LANTERN PHARMA INC.
SALE
12,319$3.09$38.1K323,335Jun 13, 2025Jun 13, 2025 ↗View →
LTRN
LANTERN PHARMA INC.
SALE
4,354$3.09$13.5K114,272Jun 13, 2025Jun 13, 2025 ↗View →
LTRN
LANTERN PHARMA INC.
SALE
14,218$3.09$43.9K373,178Jun 13, 2025Jun 13, 2025 ↗View →
LTRN
LANTERN PHARMA INC.
SALE
1,903$3.09$5.9K49,957Jun 13, 2025Jun 13, 2025 ↗View →
LTRN
LANTERN PHARMA INC.
SALE
7,206$3.09$22.3K189,117Jun 13, 2025Jun 13, 2025 ↗View →
LTRN
LANTERN PHARMA INC.
SALE
21,557$3.38$72.9K387,396Jun 12, 2025Jun 12, 2025 ↗View →
LTRN
LANTERN PHARMA INC.
SALE
6,601$3.38$22.3K118,626Jun 12, 2025Jun 12, 2025 ↗View →
LTRN
LANTERN PHARMA INC.
SALE
2,886$3.38$9.8K51,860Jun 12, 2025Jun 12, 2025 ↗View →
LTRN
LANTERN PHARMA INC.
SALE
18,678$3.38$63.1K335,654Jun 12, 2025Jun 12, 2025 ↗View →
LTRN
LANTERN PHARMA INC.
SALE
10,925$3.38$36.9K196,323Jun 12, 2025Jun 12, 2025 ↗View →
LTRN
LANTERN PHARMA INC.
SALE
171$3.40$581207,248Jun 11, 2025Jun 12, 2025 ↗View →
LTRN
LANTERN PHARMA INC.
SALE
103$3.40$350125,227Jun 11, 2025Jun 12, 2025 ↗View →
LTRN
LANTERN PHARMA INC.
SALE
45$3.40$15354,746Jun 11, 2025Jun 12, 2025 ↗View →
LTRN
LANTERN PHARMA INC.
SALE
338$3.40$1.1K408,953Jun 11, 2025Jun 12, 2025 ↗View →
LTRN
LANTERN PHARMA INC.
SALE
293$3.40$996354,332Jun 11, 2025Jun 12, 2025 ↗View →
LTRN
LANTERN PHARMA INC.
SALE
5$3.40$17409,291Jun 10, 2025Jun 12, 2025 ↗View →
LTRN
LANTERN PHARMA INC.
SALE
2$3.40$7125,330Jun 10, 2025Jun 12, 2025 ↗View →
LTRN
LANTERN PHARMA INC.
SALE
3$3.40$10207,419Jun 10, 2025Jun 12, 2025 ↗View →
LTRN
LANTERN PHARMA INC.
SALE
1$3.40$354,791Jun 10, 2025Jun 12, 2025 ↗View →
LTRN
LANTERN PHARMA INC.
SALE
5$3.40$17354,625Jun 10, 2025Jun 12, 2025 ↗View →
LTRN
LANTERN PHARMA INC.
SALE
6,221$3.03$18.8K354,630May 29, 2025May 29, 2025 ↗View →
LTRN
LANTERN PHARMA INC.
SALE
961$3.03$2.9K54,792May 29, 2025May 29, 2025 ↗View →
LTRN
LANTERN PHARMA INC.
SALE
3,639$3.03$11.0K207,422May 29, 2025May 29, 2025 ↗View →
LTRN
LANTERN PHARMA INC.
SALE
2,199$3.03$6.7K125,332May 29, 2025May 29, 2025 ↗View →
LTRN
LANTERN PHARMA INC.
SALE
7,180$3.03$21.8K409,296May 29, 2025May 29, 2025 ↗View →
LTRN
LANTERN PHARMA INC.
SALE
1,632$2.87$4.7K127,531May 28, 2025May 29, 2025 ↗View →
LTRN
LANTERN PHARMA INC.
SALE
5,332$2.87$15.3K416,476May 28, 2025May 29, 2025 ↗View →
LTRN
LANTERN PHARMA INC.
SALE
2,702$2.87$7.8K211,061May 28, 2025May 29, 2025 ↗View →
LTRN
LANTERN PHARMA INC.
SALE
4,620$2.87$13.3K360,851May 28, 2025May 29, 2025 ↗View →
LTRN
LANTERN PHARMA INC.
SALE
714$2.87$2.0K55,753May 28, 2025May 29, 2025 ↗View →
LTRN
LANTERN PHARMA INC.
SALE
3,790$3.05$11.6K213,763May 27, 2025May 29, 2025 ↗View →
LTRN
LANTERN PHARMA INC.
SALE
6,479$3.05$19.8K365,471May 27, 2025May 29, 2025 ↗View →
LTRN
LANTERN PHARMA INC.
SALE
7,478$3.05$22.8K421,808May 27, 2025May 29, 2025 ↗View →
LTRN
LANTERN PHARMA INC.
SALE
2,290$3.05$7.0K129,163May 27, 2025May 29, 2025 ↗View →
LTRN
LANTERN PHARMA INC.
SALE
1,000$3.05$3.0K56,467May 27, 2025May 29, 2025 ↗View →
INAB
IN8BIO, INC.
PURCHASE
709,040——709,040Oct 4, 2024Oct 11, 2024 ↗View →
INAB
IN8BIO, INC.
PURCHASE
709,040——1,283,281Oct 4, 2024Oct 11, 2024 ↗View →
INAB
IN8BIO, INC.
PURCHASE
574,241——0Oct 4, 2024Oct 11, 2024 ↗View →
INAB
IN8BIO, INC.
PURCHASEGRANT
Stock grant
574,241——574,241Oct 4, 2024Oct 11, 2024 ↗View →
ACTU
ACTUATE THERAPEUTICS, INC.
PURCHASE
525,797——525,797Aug 14, 2024Aug 14, 2024 ↗View →
ACTU
ACTUATE THERAPEUTICS, INC.
SALE
2,022,029——0Aug 14, 2024Aug 14, 2024 ↗View →
ACTU
ACTUATE THERAPEUTICS, INC.
SALE
101,900——0Aug 14, 2024Aug 14, 2024 ↗View →
ACTU
ACTUATE THERAPEUTICS, INC.
PURCHASE
309,589——309,589Aug 14, 2024Aug 14, 2024 ↗View →
ACTU
ACTUATE THERAPEUTICS, INC.
SALE
141,457——0Aug 14, 2024Aug 14, 2024 ↗View →
ACTU
ACTUATE THERAPEUTICS, INC.
PURCHASE
147,047——300,749Aug 14, 2024Aug 14, 2024 ↗View →
ACTU
ACTUATE THERAPEUTICS, INC.
SALE
23,628——0Aug 14, 2024Aug 14, 2024 ↗View →
ACTU
ACTUATE THERAPEUTICS, INC.
PURCHASE
54,032——195,489Aug 14, 2024Aug 14, 2024 ↗View →
ACTU
ACTUATE THERAPEUTICS, INC.
PURCHASE
2,022,029——2,022,029Aug 14, 2024Aug 14, 2024 ↗View →
ACTU
ACTUATE THERAPEUTICS, INC.
PURCHASE
884,427——884,427Aug 14, 2024Aug 14, 2024 ↗View →
ACTU
ACTUATE THERAPEUTICS, INC.
SALE
309,589——0Aug 14, 2024Aug 14, 2024 ↗View →
ACTU
ACTUATE THERAPEUTICS, INC.
PURCHASE
23,628——85,485Aug 14, 2024Aug 14, 2024 ↗View →
ACTU
ACTUATE THERAPEUTICS, INC.
PURCHASE
78,267——404,814Aug 14, 2024Aug 14, 2024 ↗View →
ACTU
ACTUATE THERAPEUTICS, INC.
PURCHASE
153,702——153,702Aug 14, 2024Aug 14, 2024 ↗View →
ACTU
ACTUATE THERAPEUTICS, INC.
PURCHASE
307,538——307,538Aug 14, 2024Aug 14, 2024 ↗View →
ACTU
ACTUATE THERAPEUTICS, INC.
SALE
484,638——0Aug 14, 2024Aug 14, 2024 ↗View →
ACTU
ACTUATE THERAPEUTICS, INC.
PURCHASE
462,073——462,073Aug 14, 2024Aug 14, 2024 ↗View →
ACTU
ACTUATE THERAPEUTICS, INC.
SALE
2,324$9.00$20.9K131,248Aug 14, 2024Aug 14, 2024 ↗View →
ACTU
ACTUATE THERAPEUTICS, INC.
SALE
54,032——0Aug 14, 2024Aug 14, 2024 ↗View →
ACTU
ACTUATE THERAPEUTICS, INC.
SALE
147,047——0Aug 14, 2024Aug 14, 2024 ↗View →
ACTU
ACTUATE THERAPEUTICS, INC.
SALE
78,267——0Aug 14, 2024Aug 14, 2024 ↗View →
ACTU
ACTUATE THERAPEUTICS, INC.
PURCHASE
74,202——383,791Aug 14, 2024Aug 14, 2024 ↗View →
ACTU
ACTUATE THERAPEUTICS, INC.
SALE
462,073——0Aug 14, 2024Aug 14, 2024 ↗View →
ACTU
ACTUATE THERAPEUTICS, INC.
SALE
307,538——0Aug 14, 2024Aug 14, 2024 ↗View →
ACTU
ACTUATE THERAPEUTICS, INC.
SALE
176,499——0Aug 14, 2024Aug 14, 2024 ↗View →
ACTU
ACTUATE THERAPEUTICS, INC.
SALE
332,867——0Aug 14, 2024Aug 14, 2024 ↗View →
ACTU
ACTUATE THERAPEUTICS, INC.
PURCHASE
3,528$5.27$18.6K133,572Aug 14, 2024Aug 14, 2024 ↗View →
ACTU
ACTUATE THERAPEUTICS, INC.
PURCHASE
326,547——326,547Aug 14, 2024Aug 14, 2024 ↗View →
ACTU
ACTUATE THERAPEUTICS, INC.
PURCHASE
44,559——130,044Aug 14, 2024Aug 14, 2024 ↗View →
ACTU
ACTUATE THERAPEUTICS, INC.
PURCHASE
125,000$8.00$1.00M125,000Aug 14, 2024Aug 14, 2024 ↗View →
ACTU
ACTUATE THERAPEUTICS, INC.
SALE
17,361$9.00$156.2K980,433Aug 14, 2024Aug 14, 2024 ↗View →
ACTU
ACTUATE THERAPEUTICS, INC.
SALE
884,427——0Aug 14, 2024Aug 14, 2024 ↗View →
ACTU
ACTUATE THERAPEUTICS, INC.
SALE
74,202——0Aug 14, 2024Aug 14, 2024 ↗View →
ACTU
ACTUATE THERAPEUTICS, INC.
SALE
61,857——0Aug 14, 2024Aug 14, 2024 ↗View →
ACTU
ACTUATE THERAPEUTICS, INC.
SALE
3,528——0Aug 14, 2024Aug 14, 2024 ↗View →
ACTU
ACTUATE THERAPEUTICS, INC.
SALE
5,314$9.00$47.8K300,143Aug 14, 2024Aug 14, 2024 ↗View →
ACTU
ACTUATE THERAPEUTICS, INC.
PURCHASE
26,355$5.27$138.9K997,794Aug 14, 2024Aug 14, 2024 ↗View →
ACTU
ACTUATE THERAPEUTICS, INC.
SALE
573,394——0Aug 14, 2024Aug 14, 2024 ↗View →
ACTU
ACTUATE THERAPEUTICS, INC.
PURCHASE
332,867——971,439Aug 14, 2024Aug 14, 2024 ↗View →
ACTU
ACTUATE THERAPEUTICS, INC.
SALE
525,797——0Aug 14, 2024Aug 14, 2024 ↗View →
ACTU
ACTUATE THERAPEUTICS, INC.
PURCHASE
8,068$5.27$42.5K305,457Aug 14, 2024Aug 14, 2024 ↗View →
ACTU
ACTUATE THERAPEUTICS, INC.
SALE
2,094,650——0Aug 14, 2024Aug 14, 2024 ↗View →
ACTU
ACTUATE THERAPEUTICS, INC.
SALE
44,559——0Aug 14, 2024Aug 14, 2024 ↗View →
ACTU
ACTUATE THERAPEUTICS, INC.
PURCHASE
176,499——638,572Aug 14, 2024Aug 14, 2024 ↗View →
ACTU
ACTUATE THERAPEUTICS, INC.
SALE
153,702——0Aug 14, 2024Aug 14, 2024 ↗View →
ACTU
ACTUATE THERAPEUTICS, INC.
SALE
8,068——0Aug 14, 2024Aug 14, 2024 ↗View →
ACTU
ACTUATE THERAPEUTICS, INC.
PURCHASE
2,094,650——2,094,650Aug 14, 2024Aug 14, 2024 ↗View →
ACTU
ACTUATE THERAPEUTICS, INC.
PURCHASE
573,394——573,394Aug 14, 2024Aug 14, 2024 ↗View →
ACTU
ACTUATE THERAPEUTICS, INC.
PURCHASE
141,457——141,457Aug 14, 2024Aug 14, 2024 ↗View →
ACTU
ACTUATE THERAPEUTICS, INC.
PURCHASE
61,857——61,857Aug 14, 2024Aug 14, 2024 ↗View →
ACTU
ACTUATE THERAPEUTICS, INC.
SALE
326,547——0Aug 14, 2024Aug 14, 2024 ↗View →
ACTU
ACTUATE THERAPEUTICS, INC.
PURCHASE
484,638——2,506,667Aug 14, 2024Aug 14, 2024 ↗View →
ACTU
ACTUATE THERAPEUTICS, INC.
PURCHASE
101,900——297,389Aug 14, 2024Aug 14, 2024 ↗View →
ACTU
ACTUATE THERAPEUTICS, INC.
SALE
26,355——0Aug 14, 2024Aug 14, 2024 ↗View →
ACTU
ACTUATE THERAPEUTICS, INC.
PURCHASE
375,000$8.00$3.00M1,259,427Aug 14, 2024Aug 14, 2024 ↗View →
ACTU
ACTUATE THERAPEUTICS, INC.
SALE
5,314$8.00$42.5K300,143Aug 14, 2024Aug 20, 2024 ↗View →
ACTU
ACTUATE THERAPEUTICS, INC.
SALE
2,324$8.00$18.6K131,248Aug 14, 2024Aug 20, 2024 ↗View →
ACTU
ACTUATE THERAPEUTICS, INC.
SALE
17,361$8.00$138.9K980,433Aug 14, 2024Aug 20, 2024 ↗View →
ACTU
ACTUATE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
15,000——15,000Aug 12, 2024Aug 14, 2024 ↗View →
CGTX
COGNITION THERAPEUTICS INC
PURCHASEGRANT
Stock grant
8,500——8,500Jun 7, 2024Jun 11, 2024 ↗View →
CGTX
COGNITION THERAPEUTICS INC
PURCHASEGRANT
Stock grant
8,500——14,500Jun 7, 2024Jun 11, 2024 ↗View →
LTRN
LANTERN PHARMA INC.
SALE
4,253$6.33$26.9K131,453May 24, 2024May 28, 2024 ↗View →
LTRN
LANTERN PHARMA INC.
SALE
1,859$6.33$11.8K57,467May 24, 2024May 28, 2024 ↗View →
LTRN
LANTERN PHARMA INC.
SALE
13,888$6.33$87.9K429,286May 24, 2024May 28, 2024 ↗View →
LTRN
LANTERN PHARMA INC.
SALE
6,944$6.25$43.4K443,174May 23, 2024May 28, 2024 ↗View →
LTRN
LANTERN PHARMA INC.
SALE
930$6.25$5.8K59,326May 23, 2024May 28, 2024 ↗View →
LTRN
LANTERN PHARMA INC.
SALE
2,126$6.25$13.3K135,706May 23, 2024May 28, 2024 ↗View →
LTRN
LANTERN PHARMA INC.
SALE
13,686$4.87$66.7K450,118Feb 29, 2024Feb 29, 2024 ↗View →
LTRN
LANTERN PHARMA INC.
SALE
1,832$4.87$8.9K60,256Feb 29, 2024Feb 29, 2024 ↗View →
LTRN
LANTERN PHARMA INC.
SALE
4,185$4.87$20.4K137,832Feb 29, 2024Feb 29, 2024 ↗View →
LTRN
LANTERN PHARMA INC.
SALE
15,780$4.85$76.5K142,017Feb 28, 2024Feb 29, 2024 ↗View →
LTRN
LANTERN PHARMA INC.
SALE
6,909$4.85$33.5K62,088Feb 28, 2024Feb 29, 2024 ↗View →
LTRN
LANTERN PHARMA INC.
SALE
51,608$4.85$250.3K463,804Feb 28, 2024Feb 29, 2024 ↗View →
LTRN
LANTERN PHARMA INC.
SALE
4,649$4.40$20.5K68,997Feb 27, 2024Feb 29, 2024 ↗View →
LTRN
LANTERN PHARMA INC.
SALE
34,731$4.40$152.8K515,412Feb 27, 2024Feb 29, 2024 ↗View →
LTRN
LANTERN PHARMA INC.
SALE
10,620$4.40$46.7K157,797Feb 27, 2024Feb 29, 2024 ↗View →
LTRN
LANTERN PHARMA INC.
SALE
16,801——0Jan 17, 2024Jan 19, 2023 ↗View →
LTRN
LANTERN PHARMA INC.
SALE
7,347——0Jan 17, 2024Jan 19, 2023 ↗View →
LTRN
LANTERN PHARMA INC.
PURCHASE
54,873$3.13$171.8K591,036Jan 17, 2024Jan 19, 2023 ↗View →
LTRN
LANTERN PHARMA INC.
SALE
40,893$4.20$171.8K550,143Jan 17, 2024Jan 19, 2023 ↗View →
LTRN
LANTERN PHARMA INC.
PURCHASE
16,801$3.13$52.6K180,938Jan 17, 2024Jan 19, 2023 ↗View →
LTRN
LANTERN PHARMA INC.
PURCHASE
7,347$3.13$23.0K79,121Jan 17, 2024Jan 19, 2023 ↗View →
LTRN
LANTERN PHARMA INC.
SALE
54,873——0Jan 17, 2024Jan 19, 2023 ↗View →
LTRN
LANTERN PHARMA INC.
SALE
5,475$4.20$23.0K73,646Jan 17, 2024Jan 19, 2023 ↗View →
LTRN
LANTERN PHARMA INC.
SALE
12,521$4.20$52.6K168,417Jan 17, 2024Jan 19, 2023 ↗View →
LTRN
LANTERN PHARMA INC.
SALE
91,708$3.44$315.5K371,950Nov 29, 2023Dec 1, 2023 ↗View →
LTRN
LANTERN PHARMA INC.
SALE
53,640$3.44$184.5K217,553Nov 29, 2023Dec 1, 2023 ↗View →
CGTX
COGNITION THERAPEUTICS INC
PURCHASEGRANT
Stock grant
500,095$1.05$525.1K500,095Nov 8, 2023Nov 13, 2023 ↗View →
AZTR
AZITRA, INC.
PURCHASE
456,412$5.00$2.28M1,747,670Jun 21, 2023Jun 23, 2023 ↗View →
AZTR
AZITRA, INC.
SALE
799,467——0Jun 21, 2023Jun 23, 2023 ↗View →
AZTR
AZITRA, INC.
PURCHASE
896,035——2,643,705Jun 21, 2023Jun 23, 2023 ↗View →
AZTR
AZITRA, INC.
SALE
397,600——0Jun 21, 2023Jun 23, 2023 ↗View →
AZTR
AZITRA, INC.
PURCHASE
73,708$5.00$368.5K282,239Jun 21, 2023Jun 23, 2023 ↗View →
AZTR
AZITRA, INC.
PURCHASE
137,186——404,767Jun 21, 2023Jun 23, 2023 ↗View →
AZTR
AZITRA, INC.
PURCHASE
25,280——137,000Jun 21, 2023Jun 23, 2023 ↗View →
AZTR
AZITRA, INC.
SALE
52,078——0Jun 21, 2023Jun 23, 2023 ↗View →
AZTR
AZITRA, INC.
SALE
808,058——0Jun 21, 2023Jun 23, 2023 ↗View →
AZTR
AZITRA, INC.
PURCHASE
467,613——467,613Jun 21, 2023Jun 23, 2023 ↗View →
AZTR
AZITRA, INC.
SALE
22,798——0Jun 21, 2023Jun 23, 2023 ↗View →
AZTR
AZITRA, INC.
PURCHASE
1,291,258——1,291,258Jun 21, 2023Jun 23, 2023 ↗View →
AZTR
AZITRA, INC.
SALE
467,613——0Jun 21, 2023Jun 23, 2023 ↗View →
AZTR
AZITRA, INC.
PURCHASE
69,880$5.00$349.4K267,581Jun 21, 2023Jun 23, 2023 ↗View →
AZTR
AZITRA, INC.
SALE
170,272——0Jun 21, 2023Jun 23, 2023 ↗View →
AZTR
AZITRA, INC.
PURCHASE
436,173——436,173Jun 21, 2023Jun 23, 2023 ↗View →
AZTR
AZITRA, INC.
SALE
101,842——0Jun 21, 2023Jun 23, 2023 ↗View →
AZTR
AZITRA, INC.
SALE
77,953——0Jun 21, 2023Jun 23, 2023 ↗View →
AZTR
AZITRA, INC.
PURCHASE
57,747——313,250Jun 21, 2023Jun 23, 2023 ↗View →
AZTR
AZITRA, INC.
PURCHASE
111,720——111,720Jun 21, 2023Jun 23, 2023 ↗View →
AZTR
AZITRA, INC.
PURCHASE
197,701——197,701Jun 21, 2023Jun 23, 2023 ↗View →
AZTR
AZITRA, INC.
PURCHASE
208,531——208,531Jun 21, 2023Jun 23, 2023 ↗View →
AZTR
AZITRA, INC.
PURCHASE
799,467——799,467Jun 21, 2023Jun 23, 2023 ↗View →
AZTR
AZITRA, INC.
SALE
130,498——0Jun 21, 2023Jun 23, 2023 ↗View →
AZTR
AZITRA, INC.
PURCHASE
834,632——834,632Jun 21, 2023Jun 23, 2023 ↗View →
AZTR
AZITRA, INC.
PURCHASE
188,810——1,023,442Jun 21, 2023Jun 23, 2023 ↗View →
AZTR
AZITRA, INC.
PURCHASE
255,503——255,503Jun 21, 2023Jun 23, 2023 ↗View →
AZTR
AZITRA, INC.
SALE
412,389——0Jun 21, 2023Jun 23, 2023 ↗View →
AZTR
AZITRA, INC.
PURCHASE
144,705——426,944Jun 21, 2023Jun 23, 2023 ↗View →
AZTR
AZITRA, INC.
SALE
123,718——0Jun 21, 2023Jun 23, 2023 ↗View →
AZTR
AZITRA, INC.
SALE
82,223——0Jun 21, 2023Jun 23, 2023 ↗View →
AZTR
AZITRA, INC.
SALE
509,141——0Jun 21, 2023Jun 23, 2023 ↗View →
AZTR
AZITRA, INC.
SALE
232,908——0Jun 21, 2023Jun 23, 2023 ↗View →
CGTX
COGNITION THERAPEUTICS INC
PURCHASEGRANT
Stock grant
6,000——6,000Jun 9, 2023Jun 13, 2023 ↗View →
CGTX
COGNITION THERAPEUTICS INC
PURCHASEGRANT
Stock grant
6,000——6,000Jun 9, 2023Jun 13, 2023 ↗View →
INAB
IN8BIO, INC.
PURCHASE
8,735$2.48$21.7K570,724Dec 12, 2022Dec 13, 2022 ↗View →
INAB
IN8BIO, INC.
PURCHASE
9,214$2.48$22.8K601,980Dec 12, 2022Dec 13, 2022 ↗View →
INAB
IN8BIO, INC.
PURCHASE
57,052$2.48$141.4K3,727,597Dec 12, 2022Dec 13, 2022 ↗View →
CGTX
COGNITION THERAPEUTICS INC
PURCHASE
1,871$2.65$5.0K309,748Nov 28, 2022Nov 29, 2022 ↗View →
CGTX
COGNITION THERAPEUTICS INC
PURCHASE
1,973$2.65$5.2K326,733Nov 28, 2022Nov 29, 2022 ↗View →
CGTX
COGNITION THERAPEUTICS INC
PURCHASE
12,220$2.65$32.4K2,021,906Nov 28, 2022Nov 29, 2022 ↗View →
CGTX
COGNITION THERAPEUTICS INC
PURCHASE
8,722$1.40$12.2K324,760Nov 16, 2022Nov 17, 2022 ↗View →
CGTX
COGNITION THERAPEUTICS INC
PURCHASE
54,009$1.40$75.6K2,009,686Nov 16, 2022Nov 17, 2022 ↗View →
CGTX
COGNITION THERAPEUTICS INC
PURCHASE
8,269$1.40$11.6K307,877Nov 16, 2022Nov 17, 2022 ↗View →
CGTX
COGNITION THERAPEUTICS INC
PURCHASE
184,270$1.20$221.1K316,038Nov 15, 2022Nov 16, 2022 ↗View →
CGTX
COGNITION THERAPEUTICS INC
PURCHASE
174,700$1.20$209.6K299,608Nov 15, 2022Nov 16, 2022 ↗View →
CGTX
COGNITION THERAPEUTICS INC
PURCHASE
1,141,030$1.20$1.37M1,955,677Nov 15, 2022Nov 16, 2022 ↗View →
LTRN
LANTERN PHARMA INC.
SALE
40,586$4.40$178.6K164,137Nov 8, 2022Nov 9, 2022 ↗View →
LTRN
LANTERN PHARMA INC.
SALE
17,748$4.40$78.1K71,774Nov 8, 2022Nov 9, 2022 ↗View →
LTRN
LANTERN PHARMA INC.
SALE
58,711$4.40$258.3K271,193Nov 8, 2022Nov 9, 2022 ↗View →
LTRN
LANTERN PHARMA INC.
SALE
100,380$4.40$441.7K463,658Nov 8, 2022Nov 9, 2022 ↗View →
LTRN
LANTERN PHARMA INC.
SALE
132,575$4.40$583.3K536,163Nov 8, 2022Nov 9, 2022 ↗View →
INAB
IN8BIO, INC.
PURCHASE
3,070$2.02$6.2K592,766Sep 28, 2022Sep 29, 2022 ↗View →
INAB
IN8BIO, INC.
PURCHASE
19,017$2.02$38.4K3,670,545Sep 28, 2022Sep 29, 2022 ↗View →
INAB
IN8BIO, INC.
PURCHASE
2,913$2.02$5.9K561,989Sep 28, 2022Sep 29, 2022 ↗View →
LTRN
LANTERN PHARMA INC.
PURCHASE
26,100$1.03$26.9K26,100Sep 2, 2022Sep 7, 2022 ↗View →
LTRN
LANTERN PHARMA INC.
SALE
5,170$5.20$26.9K20,930Sep 2, 2022Sep 7, 2022 ↗View →
LTRN
LANTERN PHARMA INC.
PURCHASE
26,100——6,438Sep 2, 2022Sep 7, 2022 ↗View →
LTRN
LANTERN PHARMA INC.
PURCHASE
6,438——0Sep 2, 2022Sep 7, 2022 ↗View →
LTRN
LANTERN PHARMA INC.
SALE
1,275$5.20$6.6K26,093Sep 2, 2022Sep 7, 2022 ↗View →
LTRN
LANTERN PHARMA INC.
PURCHASE
6,438$1.03$6.6K27,328Sep 2, 2022Sep 7, 2022 ↗View →
INAB
IN8BIO, INC.
PURCHASE
5,823$1.93$11.2K553,110Aug 17, 2022Aug 17, 2022 ↗View →
INAB
IN8BIO, INC.
PURCHASE
6,142$1.93$11.9K583,407Aug 17, 2022Aug 17, 2022 ↗View →
INAB
IN8BIO, INC.
PURCHASE
38,035$1.93$73.4K3,612,569Aug 17, 2022Aug 17, 2022 ↗View →
INAB
IN8BIO, INC.
PURCHASE
217,891$1.90$414.0K217,891Aug 16, 2022Aug 16, 2022 ↗View →
INAB
IN8BIO, INC.
PURCHASE
1,349,218$1.90$2.56M3,574,534Aug 16, 2022Aug 16, 2022 ↗View →
INAB
IN8BIO, INC.
PURCHASE
206,575$1.90$392.5K540,287Aug 16, 2022Aug 16, 2022 ↗View →
CGTX
COGNITION THERAPEUTICS INC
PURCHASE
8,335——11,054Jun 10, 2022Jun 30, 2022 ↗View →
CGTX
COGNITION THERAPEUTICS INC
PURCHASE
2,469——3,614Jun 10, 2022Jun 30, 2022 ↗View →
CGTX
COGNITION THERAPEUTICS INC
SALE
2,469——8,585Jun 10, 2022Jun 30, 2022 ↗View →
CGTX
COGNITION THERAPEUTICS INC
PURCHASE
2,469——3,614Jun 10, 2022Jun 14, 2022 ↗View →
CGTX
COGNITION THERAPEUTICS INC
SALE
2,469——8,585Jun 10, 2022Jun 14, 2022 ↗View →
CGTX
COGNITION THERAPEUTICS INC
PURCHASE
8,335——11,054Jun 10, 2022Jun 14, 2022 ↗View →
LTRN
LANTERN PHARMA INC.
SALE
60,432——0Mar 17, 2022Mar 21, 2022 ↗View →
LTRN
LANTERN PHARMA INC.
PURCHASE
35,347$110,636.11$3.91B329,904Mar 17, 2022Mar 21, 2022 ↗View →
LTRN
LANTERN PHARMA INC.
SALE
35,347——0Mar 17, 2022Mar 21, 2022 ↗View →
LTRN
LANTERN PHARMA INC.
PURCHASE
60,432$189,152.16$11.43B564,038Mar 17, 2022Mar 21, 2022 ↗View →
CGTX
COGNITION THERAPEUTICS INC
PURCHASE
1,145——1,145Jan 31, 2022Jan 31, 2022 ↗View →
CGTX
COGNITION THERAPEUTICS INC
SALE
1,145——2,719Jan 31, 2022Jan 31, 2022 ↗View →
LTRN
LANTERN PHARMA INC.
PURCHASEGRANT
Stock grant
3,200——3,200Nov 4, 2021Nov 8, 2021 ↗View →
CGTX
COGNITION THERAPEUTICS INC
PURCHASE
1,424,014——1,424,014Oct 13, 2021Jan 31, 2022 ↗View →
INAB
IN8BIO, INC.
PURCHASE
12,775——12,775Aug 13, 2021Aug 17, 2021 ↗View →
INAB
IN8BIO, INC.
PURCHASE
10,500——10,500Aug 13, 2021Aug 17, 2021 ↗View →
INAB
IN8BIO, INC.
SALE
1,706,490——0Aug 3, 2021Aug 3, 2021 ↗View →
INAB
IN8BIO, INC.
PURCHASE
1,876,624——1,876,624Aug 3, 2021Aug 3, 2021 ↗View →
INAB
IN8BIO, INC.
SALE
2,023,568——0Aug 3, 2021Aug 3, 2021 ↗View →
INAB
IN8BIO, INC.
SALE
228,438——0Aug 3, 2021Aug 3, 2021 ↗View →
INAB
IN8BIO, INC.
SALE
907,007——0Aug 3, 2021Aug 3, 2021 ↗View →
INAB
IN8BIO, INC.
PURCHASE
2,225,316——2,225,316Aug 3, 2021Aug 3, 2021 ↗View →
INAB
IN8BIO, INC.
PURCHASE
340,712——340,712Aug 3, 2021Aug 3, 2021 ↗View →
INAB
IN8BIO, INC.
PURCHASE
574,432——574,432Aug 3, 2021Aug 3, 2021 ↗View →
INAB
IN8BIO, INC.
PURCHASE
359,374——359,374Aug 3, 2021Aug 3, 2021 ↗View →
INAB
IN8BIO, INC.
SALE
522,355——0Aug 3, 2021Aug 3, 2021 ↗View →
INAB
IN8BIO, INC.
PURCHASE
251,211——251,211Aug 3, 2021Aug 3, 2021 ↗View →
INAB
IN8BIO, INC.
PURCHASE
997,433——997,433Aug 3, 2021Aug 3, 2021 ↗View →
INAB
IN8BIO, INC.
SALE
309,823——0Aug 3, 2021Aug 3, 2021 ↗View →
INAB
IN8BIO, INC.
SALE
326,795——0Aug 3, 2021Aug 3, 2021 ↗View →
LTRN
LANTERN PHARMA INC.
PURCHASE
9,135——9,135Jun 15, 2020Jun 16, 2020 ↗View →
LTRN
LANTERN PHARMA INC.
SALE
169,286——0Jun 15, 2020Jun 16, 2020 ↗View →
LTRN
LANTERN PHARMA INC.
SALE
35,181——0Jun 15, 2020Jun 16, 2020 ↗View →
LTRN
LANTERN PHARMA INC.
PURCHASE
61,214——89,522Jun 15, 2020Jun 16, 2020 ↗View →
LTRN
LANTERN PHARMA INC.
SALE
262,806——0Jun 15, 2020Jun 16, 2020 ↗View →
LTRN
LANTERN PHARMA INC.
PURCHASE
294,557——294,557Jun 15, 2020Jun 16, 2020 ↗View →
LTRN
LANTERN PHARMA INC.
PURCHASE
457,282——668,738Jun 15, 2020Jun 16, 2020 ↗View →
LTRN
LANTERN PHARMA INC.
PURCHASE
139,989——204,723Jun 15, 2020Jun 16, 2020 ↗View →
LTRN
LANTERN PHARMA INC.
PURCHASE
503,606——503,606Jun 15, 2020Jun 16, 2020 ↗View →
LTRN
LANTERN PHARMA INC.
SALE
80,454——0Jun 15, 2020Jun 16, 2020 ↗View →
LTRN
LANTERN PHARMA INC.
SALE
289,429——0Jun 15, 2020Jun 16, 2020 ↗View →
Other insiders · LTRN
Loading peer insiders…
About this filer
CIK 0001813844
ROLE
10% Owner
PRIMARY
LTRN
COMPANIES
5
ACTIVE SINCE
Jun 2020
MARKETPEEL · /INSIDER/0001813844DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback